Knuff & Co LLC acquired a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 13,038 shares of the company’s stock, valued at approximately $1,675,000.
A number of other institutional investors also recently modified their holdings of MKGAF. Comprehensive Financial Planning Inc. PA acquired a new position in shares of Merck KGaA in the 2nd quarter worth approximately $134,000. Stevens Capital Partners bought a new position in Merck KGaA in the 2nd quarter valued at $220,000. BOK Financial Private Wealth Inc. acquired a new position in Merck KGaA in the second quarter worth $523,000. Compass Wealth Management LLC bought a new stake in shares of Merck KGaA during the second quarter worth $834,000. Finally, Chancellor Financial Group WB LP bought a new stake in shares of Merck KGaA during the second quarter worth $839,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
Shares of MKGAF stock opened at $167.38 on Thursday. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56. The firm’s 50 day moving average is $162.50 and its 200-day moving average is $148.28. The firm has a market capitalization of $21.63 billion, a price-to-earnings ratio of 25.55 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
